C3 glomerulopathy (C3G) and immune-complex membranoproliferative glomerulonephritis (IC-MPGN) are two diseases that have a ...

Company officials say they are focusing on "more disciplined managed products" as they prepare to exit PPOs in 2026 that currently cover 800,000 members, including 600,000 people enrolled in Medicare ...

Sarepta continues to work with regulators to complete the safety label update for Elevidys, and they are discussing an approach for risk mitigation for non-ambulatory patients.

An expert discusses how home administration of oncology drugs in the US faces significant logistical and reimbursement ...

In a press release in advance of an 8 a.m. earnings call, the company said that the second-quarter consolidated medical-care ratio of 89.4% increased 430 basis points year-over-year. The increase was ...

Medicare Advantage enrollment transforms post-acute care, impacting home health, hospice and skilled nursing services amid evolving value-based care challenges.

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

An expert discusses how integrating newer NMIBC therapies faces operational barriers including administration logistics, staff training and formulary restrictions, while solutions require better ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for value-driven solutions.

Rising Medicare exit rates among physicians, especially primary care, highlight growing dissatisfaction and administrative ...

Jeremiah Johnson, executive director of PrEP4All, an organization committed to HIV prevention and care, talks about the ...

Two PBMs, True Rx Health Strategies and Capital Rx, are using pharmacogenomics — how a person’s DNA affects their response to ...